The Supreme Court on Tuesday pulled up the Centre over the massive disparity between medicines’ maximum retail price (MRP) and procurement costs for retailers, asking why the entire system favoured manufacturers over patients. Observing that the National Pharmaceutical Pricing Authority appeared defunct, the bench noted that drug expenses constitute seventeen percent of total healthcare costs for families.